Obesity Clinical Trial
— TELE-GENOfficial title:
A Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth (TELE-GEN) Pilot Study
Verified date | August 2022 |
Source | University of Mississippi Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth (TELE-GEN) pilot study will evaluate the implementation and early efficacy of a telehealth diabetes prevention intervention for African American (AA) children (8- to 11-years) and their parents. Power to Prevent is a lifestyle diabetes prevention intervention from the Centers for Disease Control and Prevention that is based on the Diabetes Prevention Program and tailored for AA families. To investigators knowledge, this intervention has not been evaluated in a clinical trial with AA families with children at risk for type 2 diabetes mellitus (T2DM), nor been delivered via telehealth. Employing an effectiveness-implementation hybrid study design, investigators aim to concurrently (1) conduct a single arm pilot trial to assess the early efficacy of Power to Prevent delivered via telehealth to treat overweight/obesity in AA children and their parent, while (2) evaluating an implementation strategy for the uptake of the intervention by the pediatric weight management clinic at the University of Mississippi Medical Center. The primary outcome will be stabilization or reduction in BMI z-score in children (index participant) and reduction in parent BMI (co-participant). Parents (n=20) will receive the same telehealth diabetes prevention intervention, which will be delivered by a racially concordant, trained Lifestyle Coach using small-group videoconferencing (5 parents per group). Sessions will consist of nutrition and physical activity behavior change strategies (20 min), problem solving and decision-making skills to circumvent barriers to behavioral change (20 min), and family goal setting and action planning (20 min). Child and parent measures will be assessed at baseline, 12-weeks (post-intervention), and 30-weeks (follow-up). The implementation strategy has two targets: (1) the pediatric weight management clinical and clinical care team; and (2) overweight/obese pediatric patients and their overweight/obese parents. The multifaceted implementation plan includes four discrete strategies: (1) creating a new clinical team; (2) changing the service site; (3) intervening with families; and (4) assessing organizational readiness. Preliminary findings will provide data to design a full-scale study that will include a powered pilot randomized controlled trial to test the interventions effectiveness for preventing T2DM, while evaluating a refined implementation protocol.
Status | Completed |
Enrollment | 38 |
Est. completion date | December 18, 2021 |
Est. primary completion date | December 18, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 11 Years |
Eligibility | Inclusion Criteria: - AA parents (biological, grandparent, legal guardian) and their 8- to 11-year-old child residing in the same home. - One overweight/obese parent (BMI =25 kg/m2) and child (= 85th% age-/sex-specific BMI). - Parent at-risk for diabetes (American Diabetes Association risk test) AND HbA1c 5.7% - 6.4%. Exclusion Criteria: - child or parent has a history of T2DM or a screening HbA1c >6.4%; - is taking glucose-lowering medications; - is participating in a supervised weight loss program; - is pregnant or breast feeding; - has conditions limiting participation; - has undergone weight loss surgery; - is moving out-of-state within 6 months. - If a parent becomes pregnant during the study, we will include only child data (index participant) in analyses |
Country | Name | City | State |
---|---|---|---|
United States | University of Mississippi Medical Center | Jackson | Mississippi |
Lead Sponsor | Collaborator |
---|---|
University of Mississippi Medical Center |
United States,
Gamble A, Beech BM, Wade BC, Sutton VD, Lim C, Sandridge S, Welsch MA. Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth: Protocol for a Pilot Trial. JMIR Res Protoc. 2021 Mar 31;10(3):e25699. doi: 10.2196/25699. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Child tanner stage | A valid and reliable self-administered rating scale for pubertal development; 5-items. (Carskadon and Acebo, 1993) | Change from baseline in child tanner stage to 12-weeks | |
Other | Child tanner stage | A valid and reliable self-administered rating scale for pubertal development; 5-items. (Carskadon and Acebo, 1993) | Change from baseline in child tanner stage to 30-weeks | |
Primary | Child BMI z-score | Standard anthropometric procedures and a calibrated body weight scale (Seca 777 digital scale with stadiometer) will be used to measure participants' weight (0.1kg), stature (0.1 cm); child BMI percentile will be calculated using the statistic equations made available on the Centers for Disease Control and Prevention (CDC) website | Change from baseline child BMI z-score to 12-weeks | |
Primary | Child BMI z-score | Standard anthropometric procedures and a calibrated body weight scale (Seca 777 digital scale with stadiometer) will be used to measure participants' weight (0.1kg), stature (0.1 cm); child BMI percentile will be calculated using the statistic equations made available on the CDC website | Change from baseline child BMI z-score to 30-weeks | |
Primary | Parent BMI | Standard anthropometric procedures and a calibrated body weight scale will be used to measure participants' weight (0.1kg), stature (0.1 cm); after converting cm to m, BMI = kg/m2 | Change from baseline parent BMI to 12-weeks | |
Primary | Parent BMI | Standard anthropometric procedures and a calibrated body weight scale will be used to measure participants' weight (0.1kg), stature (0.1 cm); after converting cm to m, BMI = kg/m2 | Change from baseline parent BMI to 30-weeks | |
Secondary | Child physical activity | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline child physical activity to 12-weeks | |
Secondary | Child physical activity | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline child physical activity to 30-weeks | |
Secondary | Parent physical activity | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline parent physical activity to 12-weeks | |
Secondary | Parent physical activity | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline parent physical activity to 30-weeks | |
Secondary | Child out-of-school sedentary time | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline in child out-of-school sedentary time to 12-weeks | |
Secondary | Child out-of-school sedentary time | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline in child out-of-school sedentary time to 30-weeks | |
Secondary | Parent sedentary time | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline in parent sedentary time to 12-weeks | |
Secondary | Parent sedentary time | Objective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period | Change from baseline in parent sedentary time to 30-weeks | |
Secondary | Child Hemoglobin A1c | A1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 µL blood | Change from baseline child Hemoglobin A1c to 12-weeks | |
Secondary | Child Hemoglobin A1c | A1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 µL blood | Change from baseline child Hemoglobin A1c to 30-weeks | |
Secondary | Parent Hemoglobin A1c | A1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 µL blood | Change from baseline parent Hemoglobin A1c to 12-weeks | |
Secondary | Parent Hemoglobin A1c | A1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 µL blood | Change from baseline parent Hemoglobin A1c to 30-weeks | |
Secondary | Child systolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for children. | Change from baseline child systolic blood pressure to 12-weeks | |
Secondary | Child diastolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for children. | Change from baseline child diastolic blood pressure to 12-weeks | |
Secondary | Child systolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for children. | Change from baseline child systolic blood pressure to 30-weeks | |
Secondary | Child diastolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for children. | Change from baseline child diastolic blood pressure to 30-weeks | |
Secondary | Parent systolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for adults. | Change from baseline parent systolic blood pressure to 12-weeks | |
Secondary | Parent diastolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for adults. | Change from baseline parent diastolic blood pressure to 12-weeks | |
Secondary | Parent systolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for adults. | Change from baseline in parent systolic blood pressure to 30-weeks | |
Secondary | Parent diastolic blood pressure | Welch Allyn blood pressure unit following the American Heart Association guidelines for adults. | Change from baseline in parent diastolic blood pressure to 30-weeks | |
Secondary | Child resting heart rate | Welch Allyn blood pressure unit | Change from baseline in child resting heart rate to 12-weeks | |
Secondary | Child resting heart rate | Welch Allyn blood pressure unit | Change from baseline in child resting heart rate to 30-weeks | |
Secondary | Parent resting heart rate | Welch Allyn blood pressure unit | Change from baseline in parent resting heart rate to 12-weeks | |
Secondary | Parent resting heart rate | Welch Allyn blood pressure unit | Change from baseline in parent resting heart rate to 30-weeks | |
Secondary | Parent readiness to change | Adapted from Rhee et al., a 6-item instrument to assess parents readiness and intentions to make dietary, physical activity and sedentary changes. | Change from baseline in parent readiness to change to 12-weeks | |
Secondary | Parent readiness to change | Adapted from Rhee et al., a 6-item instrument to assess parents readiness and intentions to make dietary, physical activity and sedentary changes. | Change from baseline in parent readiness to change to 30-weeks | |
Secondary | Parent self-efficacy | Valid and reliable (Norma et al., 2018) 14-item instrument to measure parent efficacy for influencing children's physical activity, sedentary behavior and dietary behavior using an 11-point Likert scale; 0-not confident, 10-absolutely confident. | Change from baseline in parent self-efficacy to 12-weeks | |
Secondary | Parent self-efficacy | Valid and reliable (Norma et al., 2018) 14-item instrument to measure parent efficacy for influencing children's physical activity, sedentary behavior and dietary behavior using an 11-point Likert scale; 0-not confident, 10-absolutely confident. | Change from baseline in parent self-efficacy to 30-weeks | |
Secondary | Child self-efficacy | A 9-item valid and reliable instrument by Lassetter et al., 2014 asking children to report their confidence on a 3-point Likert scale for eating healthy and being physically active; 1 item added to assess efficacy for watching less than 2 hours of television (TV) every day. | Change from baseline in child self-efficacy to 12-weeks | |
Secondary | Child self-efficacy | A 9-item valid and reliable instrument by Lassetter et al., 2014 asking children to report their confidence on a 3-point Likert scale for eating healthy and being physically active; 1 item added to assess efficacy for watching less than 2 hours of TV every day. | Change from baseline in child self-efficacy to 30-weeks | |
Secondary | Parent perceived family functioning | McMaster Family Assessment Device; a valid and reliable 60-item instrument using a 4-point Likert scale; subscales include problem solving, communication, roles, affective responsiveness, affective involvement, behavior control, general functioning | Change from baseline in parent perceived family functioning to 12-weeks | |
Secondary | Parent perceived family functioning | McMaster Family Assessment Device; a valid and reliable 60-item instrument using a 4-point Likert scale; subscales include problem solving, communication, roles, affective responsiveness, affective involvement, behavior control, general functioning | Change from baseline in parent perceived family functioning to 30-weeks | |
Secondary | Home physical activity and food environment | The Home Environment Survey; valid and reliable instrument (Gattshall et al., 2008) to measure the physical and social environment for food and physical activity; modified to include the physical and social environment for TV time (sedentary behavior); modified to include 79-items total; Dimensions: physical activity availability and accessibility of physical activity equipment, technology and food (i.e. fruit and vegetables); parental role modeling of physical activity, sedentary behavior, and dietary behavior. | Change from baseline in parent perceived home physical activity and food environment to 12-weeks | |
Secondary | Home physical activity and food environment | The Home Environment Survey; valid and reliable instrument (Gattshall et al., 2008) to measure the physical and social environment for food and physical activity; modified to include the physical and social environment for TV time (sedentary behavior); modified to include 79-items total; Dimensions: physical activity availability and accessibility of physical activity equipment, technology and food (i.e. fruit and vegetables); parental role modeling of physical activity, sedentary behavior, and dietary behavior. | Change from baseline in parent perceived home physical activity and food environment to 30-weeks | |
Secondary | Parent perceived child obesity-related behavior | Child Obesity Behavior Scale; adapted from Rhee et al., 2014; 20-items to measure food, physical activity and sedentary behavior quantity and frequency. | Change from baseline in parent perceived child health behavior to 12-weeks | |
Secondary | Parent perceived child obesity-related behavior | Child Obesity Behavior Scale; adapted from Rhee et al., 2014; 20-items to measure food, physical activity and sedentary behavior quantity and frequency. | Change from baseline in parent perceived child health behavior to 30-weeks | |
Secondary | Child perceived obesity-related behavior | Healthy Eating and Physical Activity Recall Questionnaire; 9-items (Lassettter et al., 2017); modified to include questions for sedentary environment; 5-items. | Change from baseline in child health behavior to 12-weeks | |
Secondary | Child perceived obesity-related behavior | Healthy Eating and Physical Activity Recall Questionnaire; 9-items (Lassettter et al., 2017); modified to include questions for sedentary environment; 5-items. | Change from baseline in child health behavior to 30-weeks | |
Secondary | Neighborhood Perception Survey | Valid and reliable 31-item instrument used by Mujahod et al., 2007 to assess 7 dimensions of neighborhood: aesthetic quality, walking environment, availability of healthy foods, safety, violence, social cohesion, activities with neighbors. | Change from baseline in parent neighborhood perception to 12-weeks | |
Secondary | Neighborhood Perception Survey | Valid and reliable 31-item instrument used by Mujahod et al., 2007 to assess 7 dimensions of neighborhood: aesthetic quality, walking environment, availability of healthy foods, safety, violence, social cohesion, activities with neighbors. | Change from baseline in parent neighborhood perception to 30-weeks | |
Secondary | Child waist circumference | A Seca 203 circumference measuring tape will be used to assess participants waist circumference. | Change from baseline in child waist circumference to 12-weeks | |
Secondary | Child waist circumference | A Seca 203 circumference measuring tape will be used to assess participants waist circumference. | Change from baseline in child and parent waist circumference to 30-weeks | |
Secondary | Parent waist circumference | A Seca 203 circumference measuring tape will be used to assess participants waist circumference. | Change from baseline in parent waist circumference to 12-weeks | |
Secondary | Parent waist circumference | A Seca 203 circumference measuring tape will be used to assess participants waist circumference. | Change from baseline in parent waist circumference to 30-weeks | |
Secondary | Parent stress | Perceived Stress Scale; 10-items (Cohen, 1994) | Change from baseline in parent stress to 12-weeks | |
Secondary | Parent stress | Perceived Stress Scale; 10-items (Cohen, 1994) | Change from baseline in parent stress to 30-weeks | |
Secondary | Child stress | PROMIS Pediatric Psychological and Physical Stress Scale; 19-items and 26-items (Bevans et al., 2018) | Change from baseline in parent stress to 12-weeks | |
Secondary | Child stress | PROMIS Pediatric Psychological and Physical Stress Scale; 19-items and 26-items (Bevans et al., 2018) | Change from baseline in parent stress to 30-weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |